利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

205 条记录 (耗时 0.03 秒)

    Deasphalting process comprising power recovery from the stage of separating deasphalted oil from the deasphalting solvent
    72.
    发明授权
    Deasphalting process comprising power recovery from the stage of separating deasphalted oil from the deasphalting solvent 失效
    脱沥青方法包括从脱沥青溶剂中分离脱沥青油的阶段的功率回收

    公开(公告)号：US4784753A

    公开(公告)日：1988-11-15

    申请号：US920090

    申请日：1986-10-17

    申请人： Gerard Hotier ,  Pierre Renard

    发明人： Gerard Hotier ,  Pierre Renard

    IPC分类号： C10C3/08 ,  C10C3/18 ,  C10G21/00 ,  C10G21/28 ,  C10G53/04 ,  C10C3/00

    CPC分类号： C10G21/003 ,  C10G21/28

    摘要： In a deasphalting process wherein the deasphalted oil is separated from the deasphalting solvent, the invention consists of performing said separation in at least two separate steps, differing by their temperatures, and of recovering heat from the deasphalted oil.The oil to be deasphalted (26) passes through an extractor (1), then through heat recuperators (3) and (4). The oil-solvent separation is achieved in two steps (5) and (11), under supercritical conditions, at different temperatures. The process has the particular advantage of saving power since external heat is provided (10) to only part of the charge.

    摘要翻译： 在脱沥青方法中，脱沥青油与脱沥青溶剂分离，本发明包括在至少两个独立的步骤中进行分离，其温度不同，并从脱沥青油中回收热量。 要脱沥青的油（26）通过萃取器（1），然后通过热回收器（3）和（4）。 油溶剂分离在两个步骤（5）和（11）中，在超临界条件下，在不同温度下实现。 该过程具有节省电力的特别优点，因为提供外部热量（10）仅限于部分电荷。

    Continuous process for the production of maeamic acids
    74.
    发明授权
    Continuous process for the production of maeamic acids 失效
    连续生产草酸的方法

    公开(公告)号：US4042620A

    公开(公告)日：1977-08-16

    申请号：US571108

    申请日：1975-04-24

    申请人： Jean Laforest ,  Louis Silhol ,  Pierre Renard

    发明人： Jean Laforest ,  Louis Silhol ,  Pierre Renard

    IPC分类号： C07C51/00

    摘要： A continuous process is provided for the preparation of a maleamic acid of the formula: ##STR1## in which: R represents a linear or branched alkylene, arylene, aralkylene, alkylarylene or cycloalkylene radical or a divalent heterocyclic radical, the free valencies of which are attached to carbon atoms, the radical containing 2 to 20 carbon atoms and X represents either a hydrogen atom or the radical: ##STR2## which comprises passing a solution of a primary monoamine or diamine and a solution of maleic anhydride in amounts such that there is a 5 to 20 mol % excess of anhydride, at a temperature of from 40.degree. to 130.degree. C and at a rate greater than 7 m/second through an injection nozzle into a twin screw reactor, the solvent for the primary amine being the same as, or compatible with, the solvent for the maleic anhydride. This process eliminates clogging problems.

    摘要翻译： 提供用于制备下式的马来酰胺酸的连续方法：其中：R表示直链或支链亚烷基，亚芳基，亚芳基亚烷基，亚烷基亚芳基或亚环烷基或二价杂环基，其自由基为 含有2至20个碳原子的基团，X表示氢原子或基团：包括使原始单胺或二胺的溶液和马来酸酐溶液的量通过，使得存在 5至20mol％过量的酸酐，在40至130℃的温度下以大于7m / s的速率通过注射嘴进入双螺杆反应器中，伯胺的溶剂相同 与马来酸酐的溶剂一样或相容。 这个过程消除了堵塞问题。

    Thiadiazine derivatives and use thereof as positive ampa receptor modulators
    76.
    发明申请
    Thiadiazine derivatives and use thereof as positive ampa receptor modulators 失效
    噻二嗪衍生物及其作为正安培受体调节剂的用途

    公开(公告)号：US20070004709A1

    公开(公告)日：2007-01-04

    申请号：US10555743

    申请日：2004-05-04

    申请人： Pierre Francotte ,  Stephane Boverie ,  Pascal De Tullio ,  Bernard Pirotte ,  Pierre Lestage ,  Laurence Danober ,  Pierre Renard ,  Daniel-Henri Caignard

    发明人： Pierre Francotte ,  Stephane Boverie ,  Pascal De Tullio ,  Bernard Pirotte ,  Pierre Lestage ,  Laurence Danober ,  Pierre Renard ,  Daniel-Henri Caignard

    IPC分类号： A61K31/549 ,  C07D498/02

    CPC分类号： C07D513/04

    摘要： Compounds of formula (I): wherein: A represents thienyl, furyl, pyrrolyl, oxathiol, thiazole, isothiazole, oxazole or imidazole, represents a single bond or a double bond, R1 represents hydrogen, linear or branched (C1-C6)alkyl optionally substituted by one or more groups selected from halogen or (C1-C6)alkoxy-(C1-C6)alkyl, R2 represents hydrogen or linear or branched (C1-C6)alkyl group optionally substituted by one or more halogen, R3 represents hydrogen or a group selected from linear or branched (C1-C6)alkyl, CONHR′ and SO2NHR′ wherein R′ represents linear or branched (C1-C6)alkyl, its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base. Medicinal products containing the same, which are useful as AMPA inhibitors.

    摘要翻译： 式（I）化合物：其中：A表示噻吩基，呋喃基，吡咯基，氧硫杂环戊烷，噻唑，异噻唑，恶唑或咪唑，表示单键或双键，R <1 表示任选被一个或多个选自卤素或（C 1 -C 6）烷基的基团取代的直链或支链（C 1 -C 6 -C 6）烷基， -C 6 -C 6烷氧基 - （C 1 -C 6 -C 6）烷基，R 2表示氢或直链或 任选被一个或多个卤素取代的支链（C 1 -C 6 -C 6）烷基，R 3 3表示氢或选自直链或 支链（C 1 -C 6 -C 6）烷基，CONHR'和SO 2 NHR'，其中R'表示直链或支链（C 1 -C 6） 1 -C 6烷基，其对映体和非对映异构体及其加成盐w 具有药学上可接受的酸或碱。 含有该药物的药物，可用作AMPA抑制剂。